Boston, MA -- (SBWIRE) -- 12/25/2013 -- Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the disease in the next 20 years. With limited effectiveness from pharmacotherapy, medical device therapy has the potential for significant adoption in the treatment of resistive hypertension and uncontrolled hypertension, once efficacy and cost-effectiveness are proven. Additionally, the degree of blood pressure reduction found in long-term clinical trials from such a well-tolerated procedure has generated notable optimism about the intervention's application in other conditions where hyperactivity of the sympathetic nervous system plays a significant role, such as congestive heart failure.

View Full Report Details and Table of Contents

The report identifies and analyzes the key companies shaping and driving the global renal denervation market. The report provides insight into the competitive renal denervation landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by GlobalData's team of industry experts.

Scope

- Investigation of current and future market competition for renal denervation
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using renal denervation devices in clinical practice.

Reasons to Get This Report

- Gain a high level view of the trends shaping and driving the renal denervation market for coronary applications and peripheral applications in the lower extremity.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Companies Mentioned in this Report: Ablative Solutions, ApexNano, Best Medical International, Boston Scientific Corporation, Cardiosonic, Covidien, Cordis Corporation and Johnson & Johnson, Cryomend, Kona Medical, Medtronic, Mercator MedSystems, Northwind Medical, ReCor Medical, Sound Interventions, St. Jude Medical, Symple Surgical, Terumo Corporation, Verve Medical

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- MediPoint: Renal Denervation - Global Analysis and Market Forecasts
- MediPoint: Renal Denervation - EU Analysis and Market Forecasts
- MediPoint: Renal Denervation - APAC Analysis and Market Forecasts
- MediPoint: Renal Denervation - US Analysis and Market Forecasts
- MediPoint: Renal Denervation - South American Analysis and Market Forecasts
- MediPoint: Bioabsorbable Stents - Current and Future Players
- MediPoint: Total Shoulder Replacement - Current and Future Players
- MediPoint: Total Ankle Replacement - Current and Future Players
- MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players
- MediPoint: Total Wrist Reconstruction - Current and Future Players